DUAL- VERSUS MONO-ANTIPLATELET THERAPY IN PATIENTS UNDERGOING TAVR: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS AND OBSERVATIONAL STUDIES

Journal of the American College of Cardiology(2018)

引用 0|浏览10
暂无评分
摘要
Current guidelines recommend dual-antiplatelet strategy (DAPT) following transcatheter aortic valve replacement (TAVR), however some studies have suggested that mono-antiplatelet strategy (MAPT) may be equally efficacious with an improved safety profile.We conducted a meta-analysis of prospective
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要